# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-002281
Filing Date
2022-02-28
Accepted
2022-02-28 16:04:15
Documents
105
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | pcvx-20211231.htm iXBRL | 10-K | 4476634
2 | EX-23.1 | pcvx-ex23_1.htm | EX-23.1 | 4020
3 | EX-31.1 | pcvx-ex31_1.htm | EX-31.1 | 28638
4 | EX-31.2 | pcvx-ex31_2.htm | EX-31.2 | 28649
5 | EX-32.1 | pcvx-ex32_1.htm | EX-32.1 | 10344
6 | EX-32.2 | pcvx-ex32_2.htm | EX-32.2 | 10345
7 | GRAPHIC | img69628308_0.jpg | GRAPHIC | 235163
8 | GRAPHIC | img69628308_1.jpg | GRAPHIC | 6693
9 | GRAPHIC | img69628308_2.jpg | GRAPHIC | 26501
10 | GRAPHIC | img69628308_3.jpg | GRAPHIC | 30980
11 | GRAPHIC | img69628308_4.jpg | GRAPHIC | 18914
12 | GRAPHIC | img69628308_5.jpg | GRAPHIC | 11932
13 | GRAPHIC | img69628308_6.jpg | GRAPHIC | 14513
14 | GRAPHIC | img69628308_7.jpg | GRAPHIC | 402260
15 | GRAPHIC | img69628308_8.jpg | GRAPHIC | 11881
16 | GRAPHIC | img69628308_9.jpg | GRAPHIC | 6365
17 | GRAPHIC | img69628308_10.jpg | GRAPHIC | 86469
18 | GRAPHIC | img69628308_11.jpg | GRAPHIC | 59731
19 | GRAPHIC | img69628308_12.jpg | GRAPHIC | 99696
20 | GRAPHIC | img69628308_13.jpg | GRAPHIC | 95783
21 | GRAPHIC | img69628308_14.jpg | GRAPHIC | 17663
22 | GRAPHIC | img69628308_15.jpg | GRAPHIC | 60703
23 | GRAPHIC | img69628308_16.jpg | GRAPHIC | 73536
24 | GRAPHIC | img69628308_17.jpg | GRAPHIC | 114861
25 | GRAPHIC | img69628308_18.jpg | GRAPHIC | 23690
26 | GRAPHIC | img69628308_19.jpg | GRAPHIC | 10641
27 | GRAPHIC | img69628308_20.jpg | GRAPHIC | 147161
28 | GRAPHIC | img69628308_21.jpg | GRAPHIC | 39238
| Complete submission text file | 0000950170-22-002281.txt |  | 16908489

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
29 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | pcvx-20211231.xsd | EX-101.SCH | 74314
30 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | pcvx-20211231_def.xml | EX-101.DEF | 274495
31 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | pcvx-20211231_lab.xml | EX-101.LAB | 605338
32 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | pcvx-20211231_pre.xml | EX-101.PRE | 462729
33 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | pcvx-20211231_cal.xml | EX-101.CAL | 70324
99 | EXTRACTED XBRL INSTANCE DOCUMENT | pcvx-20211231_htm.xml | XML | 2231315

Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39323 | Film No.: 22689271
SIC: 2836 Biological Products, (No Diagnostic Substances)